Cyhoeddiad
2026
- Hamilton, R. et al. 2026. Multi-centre randomised controlled feasibility trial with embedded process evaluation of a samba percussion intervention for people living with Parkinson’s disease: a protocol for the Sparky Samba trial. BMJ Open 16 (9) e114372. (10.1136/bmjopen-2025-114372)
- Saxena, A. et al., 2026. Everolimus for the treatment of neuropsychological deficits in tuberous sclerosis complex: findings from the TRON multicentre randomised controlled trial. Journal of Medical Genetics (10.1136/jmg-2026-111529)
2025
- McGrath, E. R. , Kirby, N. and Shiely, F. 2025. Use of participant data and biological samples is insufficiently described in participant information leaflets. Journal of Clinical Epidemiology 177 111590. (10.1016/j.jclinepi.2024.111590)
2023
- Stathi, A. et al., 2023. A peer-volunteer led active ageing programme to prevent decline in physical function in older people at risk of mobility disability (Active, Connected, Engaged [ACE]): study protocol for a randomised controlled trial. Trials 24 (1) 772. (10.1186/s13063-023-07758-3)
2022
- Markoulidakis, A. et al. 2022. Lifestyle index for individuals with HD (LifeHD): an aggregated measure that characterises the lifestyle habits of individuals with HD. Presented at: EHDN 2022 Plenary Meeting Bologna, Italy 16-18 September. Vol. 93.Vol. S1. (10.1136/jnnp-2022-ehdn.111)
- Mullins, E. et al., 2022. Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study. European Journal of Obstetrics and Gynecology and Reproductive Biology 276 , pp.161-167. (10.1016/j.ejogrb.2022.07.010)
- Abbott, R. A. et al., 2022. Observational study to estimate the proportion of surgical site infection following excision of ulcerated skin tumours (OASIS study). Clinical and Experimental Dermatology 47 (5), pp.882-888. (10.1111/ced.15037)
- Milton, R. et al. 2022. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. The Lancet Global Health 10 (5), pp.e661-e672. (10.1016/S2214-109X(22)00043-2)
- Gillespie, D. et al. 2022. Associations with post-consultation health-status in primary care managed acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2022 (17), pp.383-394. (10.2147/COPD.S340710)
2021
- Woodgate, S. et al. 2021. Objectively characterizing Huntington’s disease using a novel upper limb dexterity test. Journal of Neurology 268 , pp.2550-2559. (10.1007/s00415-020-10375-8)
- Gillespie, D. et al. 2021. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice 71 (705), pp.e266-e272. (10.3399/BJGP.2020.0823)
- Metryka, A. et al., 2021. Study protocol for randomised clinical trial comparing the effectiveness of side-lying sleep positioning to back-lying at reducing oxygen desaturation resulting from obstructive sleep apnoea in infants with cleft palate (SLUMBRS2). BMJ Open 11 (4) e049290. (10.1136/bmjopen-2021-049290)
- Banerjee, J. et al., 2021. Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention. BMJ Open 11 (1) e041247. (10.1136/bmjopen-2020-041247)
2020
- Lowe, J. et al. 2020. Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ Open 10 (10) e041528. (10.1136/bmjopen-2020-041528)
- Kirby, N. et al. 2020. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials. Trials 21 (1) 658. (10.1186/s13063-020-04591-w)
- Francis, N. A. et al. 2020. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT. Health Technology Assessment 24 15. (10.3310/hta24150)
2019
- Butler, C. C. et al. 2019. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. New England Journal of Medicine 381 , pp.111-120. (10.1056/NEJMoa1803185)
- Brookes-Howell, L. et al. 2019. Challenges in managing urinary tract infection and the potential of a point-of-care test guided care in primary care: an international qualitative study. BJGP Open 3 (2) 18X101630. (10.3399/bjgpopen18X101630)
2018
- Howick, J. et al., 2018. Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials. Trials 19 (1), pp.-. 674. (10.1186/s13063-018-3042-4)
- Butler, C. C. et al. 2018. Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. British Journal of General Practice 68 (669), pp.e268-e278. (10.3399/bjgp18X695285)
2017
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67 (665), pp.e830-e841. (10.3399/bjgp17X693641)
- Bates, J. et al. 2017. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18 422. (10.1186/s13063-017-2144-8)
- Chestnutt, I. G. et al. 2017. Fissure seal or fluoride varnish? A randomised trial of their relative effectiveness. Journal of Dental Research 96 (7), pp.754-761. (10.1177/0022034517702094)
- Chestnutt, I. G. et al. 2017. Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decay. Health Technology Assessment 21 (21), pp.1-256. (10.3310/hta21210)
2016
- Randell, E. et al. 2016. The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial. Trials 17 398. (10.1186/s13063-016-1446-6)
2013
- Bates, J. et al., 2013. Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice. [Abstract]. Trials 14 (S1), pp.-. P10. (10.1186/1745-6215-14-S1-P10)
Cynadleddau
- Markoulidakis, A. et al. 2022. Lifestyle index for individuals with HD (LifeHD): an aggregated measure that characterises the lifestyle habits of individuals with HD. Presented at: EHDN 2022 Plenary Meeting Bologna, Italy 16-18 September. Vol. 93.Vol. S1. (10.1136/jnnp-2022-ehdn.111)
Erthyglau
- Hamilton, R. et al. 2026. Multi-centre randomised controlled feasibility trial with embedded process evaluation of a samba percussion intervention for people living with Parkinson’s disease: a protocol for the Sparky Samba trial. BMJ Open 16 (9) e114372. (10.1136/bmjopen-2025-114372)
- Saxena, A. et al., 2026. Everolimus for the treatment of neuropsychological deficits in tuberous sclerosis complex: findings from the TRON multicentre randomised controlled trial. Journal of Medical Genetics (10.1136/jmg-2026-111529)
- McGrath, E. R. , Kirby, N. and Shiely, F. 2025. Use of participant data and biological samples is insufficiently described in participant information leaflets. Journal of Clinical Epidemiology 177 111590. (10.1016/j.jclinepi.2024.111590)
- Stathi, A. et al., 2023. A peer-volunteer led active ageing programme to prevent decline in physical function in older people at risk of mobility disability (Active, Connected, Engaged [ACE]): study protocol for a randomised controlled trial. Trials 24 (1) 772. (10.1186/s13063-023-07758-3)
- Mullins, E. et al., 2022. Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study. European Journal of Obstetrics and Gynecology and Reproductive Biology 276 , pp.161-167. (10.1016/j.ejogrb.2022.07.010)
- Abbott, R. A. et al., 2022. Observational study to estimate the proportion of surgical site infection following excision of ulcerated skin tumours (OASIS study). Clinical and Experimental Dermatology 47 (5), pp.882-888. (10.1111/ced.15037)
- Milton, R. et al. 2022. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. The Lancet Global Health 10 (5), pp.e661-e672. (10.1016/S2214-109X(22)00043-2)
- Gillespie, D. et al. 2022. Associations with post-consultation health-status in primary care managed acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2022 (17), pp.383-394. (10.2147/COPD.S340710)
- Woodgate, S. et al. 2021. Objectively characterizing Huntington’s disease using a novel upper limb dexterity test. Journal of Neurology 268 , pp.2550-2559. (10.1007/s00415-020-10375-8)
- Gillespie, D. et al. 2021. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice 71 (705), pp.e266-e272. (10.3399/BJGP.2020.0823)
- Metryka, A. et al., 2021. Study protocol for randomised clinical trial comparing the effectiveness of side-lying sleep positioning to back-lying at reducing oxygen desaturation resulting from obstructive sleep apnoea in infants with cleft palate (SLUMBRS2). BMJ Open 11 (4) e049290. (10.1136/bmjopen-2021-049290)
- Banerjee, J. et al., 2021. Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention. BMJ Open 11 (1) e041247. (10.1136/bmjopen-2020-041247)
- Lowe, J. et al. 2020. Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ Open 10 (10) e041528. (10.1136/bmjopen-2020-041528)
- Kirby, N. et al. 2020. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials. Trials 21 (1) 658. (10.1186/s13063-020-04591-w)
- Francis, N. A. et al. 2020. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT. Health Technology Assessment 24 15. (10.3310/hta24150)
- Butler, C. C. et al. 2019. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. New England Journal of Medicine 381 , pp.111-120. (10.1056/NEJMoa1803185)
- Brookes-Howell, L. et al. 2019. Challenges in managing urinary tract infection and the potential of a point-of-care test guided care in primary care: an international qualitative study. BJGP Open 3 (2) 18X101630. (10.3399/bjgpopen18X101630)
- Howick, J. et al., 2018. Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials. Trials 19 (1), pp.-. 674. (10.1186/s13063-018-3042-4)
- Butler, C. C. et al. 2018. Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. British Journal of General Practice 68 (669), pp.e268-e278. (10.3399/bjgp18X695285)
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67 (665), pp.e830-e841. (10.3399/bjgp17X693641)
- Bates, J. et al. 2017. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18 422. (10.1186/s13063-017-2144-8)
- Chestnutt, I. G. et al. 2017. Fissure seal or fluoride varnish? A randomised trial of their relative effectiveness. Journal of Dental Research 96 (7), pp.754-761. (10.1177/0022034517702094)
- Chestnutt, I. G. et al. 2017. Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decay. Health Technology Assessment 21 (21), pp.1-256. (10.3310/hta21210)
- Randell, E. et al. 2016. The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial. Trials 17 398. (10.1186/s13063-016-1446-6)
- Bates, J. et al., 2013. Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice. [Abstract]. Trials 14 (S1), pp.-. P10. (10.1186/1745-6215-14-S1-P10)
Bywgraffiad
Rwy'n gweithio fel methodolegydd treialon uwch gyda ffocws sylfaenol ar optimeiddio ac arloesi cipio data a
rheoli i wella ansawdd, dibynadwyedd a llywodraethu data, gan alluogi clinigol o ansawdd uchel ac effeithiol
a threialon iechyd cyhoeddus.
Rwy'n arwain y tîm Data a Thechnoleg, sy'n cynnwys Rheolwyr Data, Uwch Reolwyr Data, Datblygwyr Cronfa Ddata a staff Datrysiadau Technoleg. Rwy'n goruchwylio'r holl weithgareddau Rheoli Data a Datblygu Cronfa Ddata ar draws CTR gyda chyfrifoldeb am gydymffurfiaeth reoleiddiol, fel arfer yn cefnogi tua 60 o dreialon ac astudiaethau ar unrhyw adeg. Agwedd allweddol ar fy rôl yw mentora staff ymchwil iau, eu harwain ar ddechrau eu gyrfaoedd a chefnogi eu datblygiad proffesiynol.
Yn genedlaethol, rwy'n cyfrannu'n aelod o Grŵp Gweithrediadau Data a Systemau Gwybodaeth UK Clinical Research Collaboration (UKCRC). Mae'r rôl hon yn fy ngalluogi i ddarparu cymorth cymheiriaid i gymheiriaid, arwain digwyddiadau rhwydweithio, a datblygu adnoddau i gryfhau arferion Rheoli Data ledled y DU.